Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.98
Delayed Data
As of 3:59pm ET
 +0.09 / +3.11%
Today’s Change
1.65
Today|||52-Week Range
6.49
+71.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues5.0M7.8M7.0M13.9M
 
 
 
 
 
Cost of Goods Sold--1.8M1.8M4.2M
 
 
 
 
Depreciation And Amortization78.0K116.0K1.5M2.0M
 
 
 
 
 
 
Operating ExpensesGross Income--5.9M3.7M7.7M
 
 
 
 
General Expenses28.3M39.1M40.4M48.7M
 
 
 
 
 
Research And Development11.8M14.2M5.3M6.7M
 
 
 
 
 
Total Operating Expenses28.4M41.0M43.7M54.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.3M-33.2M-36.7M-40.9M
 
 
 
 
 
Extraordinary Credit0.0011.6M86.3M26.0M
 
 
 
 
Extraordinary Charge0.000.00-1.0M-2.0M
 
 
 
Interest Expense On Debt1.9M2.0M2.0M2.0M
 
 
 
 
 
Other Expenses2.8M-1.8M786.0K-5.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.3M-25.2M47.7M-24.5M
 
 
 
 
 
Income Taxes0.000.000.00-133.0K
 
 
Net Income-22.3M-25.2M47.7M-24.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.6M14.6M14.6M14.6M
 
 
 
 
 
Shares To Calculate EPS Diluted14.6M14.6M36.6M14.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.50-$17.30$1.12-$1.69
 
 
 
 
 
EPS Diluted-$1.50-$1.73$1.12-$1.69